BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.36) by 8.33 percent. This is a 153.85 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $11.800 thousand which missed the analyst consensus estimate of $460.000 thousand by 97.43 percent. This is a 94.52 percent decrease over sales of $215.357 thousand the same period last year.